Mechanism
HPV16 E7 antigen presented on HLA-A*02:01
Assets acting on this target.
- Class
- HLA-restricted, autologous TCR-engineered T cell therapy (TCR-T)
- Pathway
- MHC class I-restricted antigen recognition driving T cell-mediated tumor cytotoxicity
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.